
3rd DEOSS Congress 2026 attracts researches and doctors to update on latest in the management of DRY EYES

3rd DEOSS Congress 2026 attracts researches and doctors to update on latest in the management of DRY EYES

Attended the Ophthalmology Conference organised by Moorfields UAE -in Dubai
today 10 Jan 2026. Excellent coverage of various eye diseases, including oculoplasty and myopia. Thanks to the Moorfields Hospital staff. Well organise event

Scientists are investigating a naturally occurring steroid called lanosterol that could be used one day to treat cataracts. It may be possible one day to use lanosterol in the form of a topical eye drop to reduce cataract development.
Lanosterol eye drops could potentially be a safe, non-invasive, and less costly alternative to cataract surgery for patients who have moderate forms of cataracts.
Scientists surmised that lanosterol functions to keep the human lens clear by stopping the breakdown and clumping of the normally clear proteins in the lens.
Lanosterol was able to significantly shrink the size of cataracts and improve lens transparency.
Scientists caution that more research is needed before deeming the drops as a safe and effective treatment for cataracts in humans. It could be a very exciting discovery.
